Literature DB >> 8980739

Histological heterogeneity of neuroradiologically suspected adult low grade gliomas detected by Xenon enhanced computerized tomography (CT).

K Roessler1, C Nasel, T Czech, C Matula, H Lassmann, W T Koos.   

Abstract

Xenon-enhanced computerized tomography (XeCT) was performed on 14 consecutive adult patients presenting with seizures showing supratentorial non-enhancing radiologically uniform appearing low grade gliomas on CT/MR images. Pre-operative XeCT patterns were compared with postoperative histological diagnosis, grading and Ki67 proliferation indices (PI). After gross-total, subtotal resection or biopsy, 11 astrocytomas, 2 oligodendrogliomas and 1 oligo-astrocytoma were diagnosed and graded: Grade I: 2 patients (Ki67-PI = 0.5-0.8), Grade I-II: 4 patients (Ki67-PI = 0.3-1.5), Grade II: 3 patients (Ki67-PI = 0.5-3.5), Grade II-III: 4 patients (Ki67-PI = 3.8-6.8) and Grade III: 1 patient (Ki67-PI = 5.2), (Kernohan Classification). Xenon CT studies revealed different flow patterns, correlating with the postoperative histological diagnosis, grading and proliferation indices: A tumour group with well defined, delayed, only minimally enhancing tumour area (5 patients, Grade I, I-II or II), a second group with less well defined low-flow-area borders and inhomogenous, strong enhancement within the tumour (4 patients, Grade II-III, III) and a third group with fast enhancing tumours was identified. The third pattern was exclusively shown in the 2 oligodendrogliomas (Grade I and II-III) and 1 oligo-astrocytoma (Grade II). The preliminary report identifies the Xenon enhance CT as a beneficial pre-operative investigation for patients with radiologically uniform appearing suspected adult supratentorial low-grade gliomas, which may give information about the presence of anaplastic foci or oligodendroglial components.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980739     DOI: 10.1007/bf01411065

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  13 in total

1.  Expression of leucocyte adhesion molecules at the human blood-brain barrier (BBB).

Authors:  K Rössler; C Neuchrist; K Kitz; O Scheiner; D Kraft; H Lassmann
Journal:  J Neurosci Res       Date:  1992-02       Impact factor: 4.164

2.  Radiation therapy in the management of low-grade supratentorial astrocytomas.

Authors:  E G Shaw; C Daumas-Duport; B W Scheithauer; D T Gilbertson; J R O'Fallon; J D Earle; E R Laws; H Okazaki
Journal:  J Neurosurg       Date:  1989-06       Impact factor: 5.115

3.  Low-grade glioma. To treat or not to treat?

Authors:  J G Cairncross; N J Laperriere
Journal:  Arch Neurol       Date:  1989-11

Review 4.  Supratentorial low-grade gliomas.

Authors:  B L Guthrie; E R Laws
Journal:  Neurosurg Clin N Am       Date:  1990-01       Impact factor: 2.509

5.  Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas.

Authors:  M C Chamberlain; J A Murovic; V A Levin
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

6.  Stereotaxic biopsy and positron emission tomography correlation of cerebral gliomas.

Authors:  C Worthington; J L Tyler; J G Villemure
Journal:  Surg Neurol       Date:  1987-01

7.  The descriptive epidemiology of primary intracranial neoplasms: the Connecticut experience.

Authors:  B S Schoenberg; B W Christine; J P Whisnant
Journal:  Am J Epidemiol       Date:  1976-11       Impact factor: 4.897

8.  Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma.

Authors:  D Kondziolka; L D Lunsford; A J Martinez
Journal:  J Neurosurg       Date:  1993-10       Impact factor: 5.115

9.  Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study.

Authors:  K Herholz; U Pietrzyk; J Voges; R Schröder; M Halber; H Treuer; V Sturm; W D Heiss
Journal:  J Neurosurg       Date:  1993-12       Impact factor: 5.115

10.  Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose.

Authors:  M Levivier; S Goldman; B Pirotte; J M Brucher; D Balériaux; A Luxen; J Hildebrand; J Brotchi
Journal:  J Neurosurg       Date:  1995-03       Impact factor: 5.115

View more
  2 in total

Review 1.  Proliferation markers in tumours: interpretation and clinical value.

Authors:  P J van Diest; G Brugal; J P Baak
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

Review 2.  The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Authors:  Sarah Jost Fouke; Tammie Benzinger; Daniel Gibson; Timothy C Ryken; Steven N Kalkanis; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2015-11-03       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.